Experience
Alumis Announces Merger With ACELYRIN
February 6, 2025
Cooley advised Alumis (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with immune-mediated diseases, on its definitive agreement with ACELYRIN to merge in an all-stock transaction.
Related contacts
Jamie Leigh
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Ben Beerle
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Polina A. Demina
Special Counsel, New York
Sangitha Palaniappa
Associate, Palo Alto
Christine Turner
Associate, Colorado
Shaun (Tianjie) Wang
Associate, New York
Megan Browdie
Partner, Washington, DC
Lauren Creel
Partner, Palo Alto
Ross Eberly
Partner, Santa Monica
Stephanie Gentile
Partner, New York
Dr. Kate Hillier
Partner, Palo Alto
Sarah Lightdale
Partner, New York
Phil Mitchell
Partner, New York
Jeremy Morrison
Partner, Washington, DC
Alessandra Murata
Partner, Palo Alto
Jennifer Raab
Partner, Palo Alto
Patrick Van Eecke
Partner, Brussels
Natasha Leskovsek
Of Counsel, Washington, DC
Julia R. Brinton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Caroline Vu
Special Counsel, Palo Alto
Christopher Andrews
Associate, New York
Dannielle Antone
Associate, San Francisco
Elizabeth Caruso
Associate, New York
Tamara Chin Loy
Associate, Washington, DC
Navya Dasari
Associate, New York
Joshua Elefant
Associate, Palo Alto
Winda Fung
Associate, Santa Monica
Gary Warren Hunt III
Associate, Washington, DC
Rachel F. Katz
Special Counsel, New York
Wyatt Kernell
Associate, Colorado
Kristina Krasnikova
Associate, Palo Alto
Sunny J. Levine
Associate, Colorado
Amanda Lindner
Associate, New York
Jayne M. Munger
Associate, New York
Julianne Orr
Associate, San Francisco
Michael Pelle
Associate, New York
Breanna Qin
Associate, Palo Alto
Bartholomäus Regenhardt
Associate, Brussels
Jesse Schulman
Associate, Colorado
Freddy Yip
Associate, Hong Kong
Isabella Ysebrands
Associate, San Francisco
Related Practices & Industries
Beta Bionics Announces Upsized $234.6 Million IPO, Concurrent $17 Million Private Placement
January 31, 2025
Cooley represented Beta Bionics, a pioneering leader in the development of advanced diabetes management solutions, in its $234.6 million initial public offering and concurrent $17 million private placement.
Related contacts
Carlos Ramirez
Partner, San Diego
Mark Weeks
Partner, Palo Alto
Charlie Kim
Partner, San Diego
Christine S. Kim
Associate, San Diego
Heidi E. Wang
Associate, San Diego
Alexis Guillermo Buz
Associate, San Diego
Joanna Zhang
Associate, San Diego
Jessica Wade
Paralegal Specialist, San Diego
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Elizabeth Caruso
Associate, New York
Sarah Miller
Associate, New York
Jessica Koffel
Special Counsel, Brussels
Thomas Welk
Senior Counsel, San Diego
Dani Nazemian
Special Counsel, San Diego
Dionne A. Thomas
Associate, San Diego
Ross Eberly
Partner, Santa Monica
Joanna Liebes Hubberts
Partner, San Diego
Chen Chen
Associate, Palo Alto
Alexandra Paterson
Associate, London
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Stephanie Gentile
Partner, New York
Calvin Lee
Associate, New York
Michael Egan
Partner, Washington, DC
Tania Soris
Associate, New York
Rebecca Ross
Special Counsel, Washington, DC
Francis Wheeler
Senior Counsel, Colorado
Related Practices & Industries
Enavate Sciences Co-Leads Normunity’s $75 Million Series B
January 13, 2025
Cooley advised Enavate Sciences, a top investment firm, as the co-lead investor in the $75 million Series B financing round of Normunity, a biotechnology company creating novel anticancer therapies. Lawyers Marc Recht, Brandon Fenn and Barry Kuang led the Cooley team advising Enavate Sciences.
Related contacts
Marc Recht
Partner, Boston
Brandon W. Fenn
Partner, New York
Barry Kuang
Associate, Boston
Liz Gold
Associate, New York
Stephanie Gentile
Partner, New York
Related Practices & Industries
H1 Acquires Ribbon Health
January 8, 2025
Cooley advised H1, a global healthcare data technology company, on its acquisition of Ribbon Health.
Related contacts
Jeff Laretto
Partner, New York
Garth Angelo Osterman
Partner, San Francisco
Nathan Baum
Special Counsel, New York
Stephanie Gentile
Partner, New York
Ryan Montgomery
Partner, Boston
Sarah Buchik
Associate, New York
Sela Dougherty
Associate, New York
Shaun (Tianjie) Wang
Associate, New York
Megan Browdie
Partner, Washington, DC
Patrick Flanagan
Partner, New York
Michael Klein
Partner, New York
Len Jacoby
Partner, New York
Kristen Mathews
Partner, New York
Phil Mitchell
Partner, New York
David Navetta
Partner, Colorado
Gerard O'Shea
Partner, New York
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Stacey A. Bradford
Special Counsel, Washington, DC
Julia R. Brinton
Special Counsel, Washington, DC
Sharon Davidov
Associate, New York
Jeremy M. Exelbert
Associate, New York
Michael Gladstone
Associate, New York
Anthony Hajj
Associate, New York
Gary Warren Hunt III
Associate, Washington, DC
Sunny J. Levine
Associate, Colorado
Amanda Pacheco
Associate, Palo Alto
Liz Paisner
Associate, New York
Katharina Schwarz
Associate, New York
Robert Warshaw
Associate, New York
Leanne Andrepont
Senior Trademark Paralegal
Patricia Myers
Paralegal Specialist, Colorado
Related Practices & Industries
Inmagene Biopharmaceuticals Announces Merger With Ikena Oncology
December 23, 2024
Cooley advised Inmagene Biopharmaceuticals, a privately held, global clinical-stage biotechnology company developing novel therapeutics for immunological and inflammatory diseases, on its definitive merger agreement with Ikena Oncology (Nasdaq: IKNA).
Related contacts
Lila Hope
Partner, Palo Alto
Rama Padmanabhan
Partner, San Diego
Patrick Loofbourrow
Partner, Singapore
Asa Henin
Partner, San Diego
Lindsey O'Crump
Associate, Washington, DC
Brittany K. Wightman
Associate, San Diego
Jiqiang Lin
Associate, New York
Leina Verrier
Associate, Santa Monica
Ross Eberly
Partner, Santa Monica
Stephanie Gentile
Partner, New York
Christopher Kimball
Partner, Washington, DC
Xander Lee
Partner, Santa Monica
Phil Mitchell
Partner, New York
Howard Morse
Senior Counsel, Washington, DC
Alessandra Murata
Partner, Palo Alto
Jean Park
Partner, New York
Aaron Pomeroy
Partner, Colorado
Michelle Garcia Schulman
Partner, Reston
Ellie Seber
Partner, Santa Monica
Marty Schenker
Senior Counsel , San Francisco
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Andrew Epstein
Special Counsel, Seattle
Stella Sarma
Partner, Brussels
Karen Tsai
Special Counsel, Washington, DC
Bin Wang
Special Counsel, Palo Alto
Robert Eisenbach
Of Counsel, San Francisco
Ajay Athavale
Associate, San Francisco
Rajdeep Roger Bains
Associate, San Diego
Julia R. Brinton
Special Counsel, Washington, DC
Elizabeth Caruso
Associate, New York
Adrienne Beaudoin Deshmukh
Associate, Reston
Jeremy M. Exelbert
Associate, New York
Daniel Gillon
Associate, San Diego
Zack Gong
Associate, Shanghai
Rick Jantz
Associate, Santa Monica
Wyatt Kernell
Associate, Colorado
Rebeca Kinslow
Associate, San Diego
Hilda Li
Associate, Hong Kong
Lunga Su
Associate, Shanghai
Novak Topalovic
Associate, San Diego
Tania Soris
Associate, New York
Christine Tse
Associate, New York
Monica Xu
Special Counsel, Shanghai
Sai Yarramalla
Associate, Palo Alto
Andy Zachrich
Associate, San Francisco
Zheng Zhou
Associate, Palo Alto
Patricia Myers
Paralegal Specialist, Colorado
Jake Ironfield
Transactional Quantitative Analyst, New York
Related Practices & Industries
Related news and events
Admissions and credentials
New York